93 related articles for article (PubMed ID: 6223572)
1. [Selective binding in vitro of a modified form of the C3 component of complement to human erythrocytes].
Micouin C; Hudry-Clergeon E; Roussel B; Battail N; Tournoud A; Colomb MG
Ann Immunol (Paris); 1983; 134C(2):237-53. PubMed ID: 6223572
[TBL] [Abstract][Full Text] [Related]
2. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
5. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
Melamed J; Medicus RG; Arnaout MA; Colten HR
J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
[TBL] [Abstract][Full Text] [Related]
6. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
7. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
Baker PJ; Adler S; Yang Y; Couser WG
J Immunol; 1984 Aug; 133(2):877-81. PubMed ID: 6376629
[TBL] [Abstract][Full Text] [Related]
8. Complement receptor expression by neoplastic and normal human cells.
Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
[TBL] [Abstract][Full Text] [Related]
9. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
Gerdes J; Klatt U; Stein H
Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
[TBL] [Abstract][Full Text] [Related]
10. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
11. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
12. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
Hänsch GM; Hammer CH; Mayer MM; Shin ML
J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
[TBL] [Abstract][Full Text] [Related]
13. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
Joiner KA; Goldman R; Schmetz M; Berger M; Hammer CH; Frank MM; Leive L
J Immunol; 1984 Jan; 132(1):369-75. PubMed ID: 6197449
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
15. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
[TBL] [Abstract][Full Text] [Related]
16. Human complement (C3b) receptors defined by a mouse monoclonal antibody.
Gerdes J; Naiem M; Mason DY; Stein H
Immunology; 1982 Apr; 45(4):645-53. PubMed ID: 7068171
[TBL] [Abstract][Full Text] [Related]
17. Complement-independent adherence of Escherichia coli to complement receptors in vitro.
Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC
J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165
[TBL] [Abstract][Full Text] [Related]
18. Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3".
Hack CE; Paardekooper J; Van Milligen F
J Immunol; 1990 Jun; 144(11):4249-55. PubMed ID: 1692860
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells.
Kubota Y; Gaither TA; Cason J; O'Shea JJ; Lawley TJ
J Immunol; 1987 Feb; 138(4):1137-42. PubMed ID: 3027170
[TBL] [Abstract][Full Text] [Related]
20. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
Berger M; Fleisher TA
J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
